About Vivalavita Pharmaceuticals Private Limited
Data last updated:
Vivalavita Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 23 February 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U52311MH2012PTC227367. Its GSTIN is 27AADCV9459Q1Z8 (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ajay Amerlal Melwani and Ayush Ajay Melwani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 301 Sainara 21 North Avenue Linking Road Junction Santacruz (West), Mumbai, Maharashtra, India – 400054.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.47 Cr. For the same year it recorded a net profit of ₹4.3 Lakh (net margin 1.7%) and EBITDA of ₹9.97 Lakh (EBITDA margin 4%). Revenue has declined at a compounded annual rate (CAGR) of 1% over three years and 10% over five years.
As per MCA filings, the company has satisfied charges of ₹2.1 Cr on record. Court records list 1 case involving the company, including 1 filed by the company.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website siriuspharmaceuticals.com.
Company details
Contact details
Vivalavita Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its website is siriuspharmaceuticals.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address301 Sainara 21 North Avenue Linking Road Junction Santacruz (West), Mumbai, Maharashtra, India – 400054
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Vivalavita Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Vivalavita Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Vivalavita Pharmaceuticals Private Limited, buy the company report.
Financials of Vivalavita Pharmaceuticals Private Limited
FY 2025 filings availableVivalavita Pharmaceuticals Private Limited reported revenue of ₹2.47 Cr for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 10% over five years. EBITDA fell 30% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹9.97 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.3 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4% | ||||
| Net Profit Margin | 1.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Vivalavita Pharmaceuticals Private Limited, buy the company report.
Board of directors of Vivalavita Pharmaceuticals Private Limited
Vivalavita Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ajay Amerlal Melwani | Director | 23 Feb 2012 | 14 Years 8 Months | Current |
| Ayush Ajay Melwani | Director | 07 Sep 2018 | 8 Years 2 Months | Current |
Auditor
Vivalavita Pharmaceuticals Private Limited is audited by PSV JAIN & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PSV JAIN & ASSOCIATES | FY 2023 | 131505W |
Shareholding
The shareholding of Vivalavita Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Vivalavita Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 22 Mar 2012 | 10342533 | Icici Bank Limited | ₹2.1 Cr | Satisfied |
To see the full charge records of Vivalavita Pharmaceuticals Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Vivalavita Pharmaceuticals Private Limited has 1 court case on record: 1 filed by Vivalavita Pharmaceuticals. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Writ petition | Filed by the company against Union of India and Anr. | Disposed |
To see the full case history of Vivalavita Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Vivalavita Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Vivalavita Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AADCV9459Q1Z8 | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Vivalavita Pharmaceuticals Private Limited, buy the company report.
Recent activity
Vivalavita Pharmaceuticals Private Limited has 4 board changes on record since 2012: 2 appointments and 2 cessations. The latest: Ayush Ajay Melwani ceased to be Additional Director on 29 Sep 2018.
Frequently asked questions
Vivalavita Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 23 February 2012 (14+ years old) and is registered under CIN U52311MH2012PTC227367.
Vivalavita Pharmaceuticals has 2 current directors:
- Ajay Amerlal Melwani - Director
- Ayush Ajay Melwani - Director
The latest financial statements of Vivalavita Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Vivalavita Pharmaceuticals is 27AADCV9459Q1Z8, registered in Maharashtra.
The CIN (Corporate Identification Number) of Vivalavita Pharmaceuticals is U52311MH2012PTC227367. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vivalavita Pharmaceuticals has 1 court case on record: 1 filed by the company.
Vivalavita Pharmaceuticals was incorporated on 23 February 2012, making it 14+ years old. It is registered with the Registrar of Companies, Mumbai.
Ayush Ajay Melwani ceased to be Additional Director on 29 Sep 2018. Neeraj Maniyar ceased to be Director on 09 Sep 2018. Ayush Ajay Melwani was appointed as Director on 07 Sep 2018. Vivalavita Pharmaceuticals has 4 board changes on record in total.
Vivalavita Pharmaceuticals can be reached through the website siriuspharmaceuticals.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Vivalavita Pharmaceuticals is at 301 Sainara 21 North Avenue Linking Road Junction Santacruz West, Mumbai, Maharashtra, India – 400054.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
